Skip to main content
. 2026 Jun 17;22(3):270–278. doi: 10.4274/ejbh.galenos.2026.2025-9-15

Table 2. Logistic regression model showing variables associated with relapse status.

Variable

OR

95% CI

p-value

ESR >20 mm/h

2.45

1.10–5.46

0.023

CRP ≥5 mg/L

1.95

0.98–4.22

0.056

TNF-a inhibitor

4.87

1.70–13.90

<0.001

Cyclosporine

3.85

1.48–10.03

0.006

Azathioprine

-

-

0.494(no relapses observed)

Age

0.98

0.93–1.03

0.398

Surgical intervention

1.55

0.82–2.91

0.184

ACE >52 U/L

2.26

1.12–4.53

0.010

TNF-a inhibitors and cyclosporine were used as rescue therapy in relapsing/refractory cases; therefore, their statistical associations with relapse should be interpreted cautiously due to confounding by indication, TNF-a: Tumor necrosis factor alpha; OR: Odds ratio; CI: Confidence interval; ESR: Erythrocyte sedimentation rate; CRP: C-reactive protein